Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs and taste aversion.

D B Rondeau, F B Jolicoeur, A D Merkel

    Neuroscience and Biobehavioral Reviews
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Phenobarbital and related drugs can reduce learned taste aversion in animal models. This drug effect is dose-dependent and influenced by the aversion

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats.

    Peptides·2006
    Same author

    Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo.

    Peptides·2004
    Same author

    Ethanol effects on dentate granule cell LTP.

    Neurotoxicity research·2004
    Same author

    Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-Schaffer collateral long-term potentiation in rats.

    Neuroscience·2003
    Same author

    Angiotensin IV enhances LTP in rat dentate gyrus in vivo.

    Peptides·2001
    Same author

    The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro.

    Brain research·2001

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Behavioral Science

    Background:

    • Taste aversion learning is a crucial survival mechanism.
    • Understanding how drugs affect this learning is important for both basic science and potential therapeutic applications.
    • Previous research has explored various factors influencing taste aversion, but the specific effects of certain sedative-hypnotics require further investigation.

    Purpose of the Study:

    • To investigate the effects of phenobarbital and related drugs on the acquisition and magnitude of taste aversion in an animal model.
    • To determine if phenobarbital's effect is dose-dependent and related to the intensity of the aversion.
    • To explore potential mechanisms underlying phenobarbital's influence on taste aversion, excluding dipsogenic and state-dependent learning effects.

    Main Methods:

    Related Experiment Videos

    • A standard taste aversion model was employed, inducing aversion using lithium chloride (LiCl) or x-radiation.
    • Test drugs, including phenobarbital, amobarbital, pentobarbital, and chlorpromazine, were administered prior to a conditioning trial.
    • The magnitude of taste aversion was assessed, and the effects of varying drug doses and aversion intensities were analyzed.

    Main Results:

    • Phenobarbital significantly attenuated taste aversion induced by LiCl and x-radiation in a dose-dependent manner, with maximal effect at 60 mg/kg.
    • The degree of aversion attenuation by phenobarbital was dependent on the initial magnitude of the taste aversion.
    • Amobarbital, pentobarbital, and chlorpromazine also showed dose-dependent attenuation of LiCl-induced taste aversion, while other barbiturates and chlordiazepoxide did not.

    Conclusions:

    • Phenobarbital and certain related drugs can effectively reduce learned taste aversion.
    • The observed effects are not solely attributable to the dipsogenic properties or state-dependent learning associated with phenobarbital.
    • These findings suggest a direct pharmacological influence of these drugs on the neural pathways involved in taste aversion learning.